5 Results for "

MLKL-IN-2

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "MLKL-IN-2" in MCE Product Catalog:

Cat. No.: HY-141889
CAS No.: 899759-16-1
Purity:  99.45%
Target:  

Mixed Lineage Kinase

Research Areas:  

Inflammation/Immunology

MLKL-IN-2 is a MLKL inhibitor extracted from patent WO2021224505A1, compound (i) .
loading...
    loading...
Cat. No.: HY-169072
CAS No.: 3103327-20-1
PROTAC MLKL Degrader-2 is an orally active and highly selective mixed lineage kinase domain-like pseudokinase (MLKL) PROTAC degrader with a DC50 of 0.012 μM. PROTAC MLKL Degrader-2 recruits the CRBN E3 ubiquitin ligase to form a ternary complex, leading to ubiquitination of MLKL and its degradation via a proteasome-dependent pathway. PROTAC MLKL Degrader-2 inhibits necroptosis, reduces ROS production, restores mitochondrial function, and ameliorates lysosomal dysfunction induced by necroptotic stimuli. PROTAC MLKL Degrader-2 degrades MLKL in xenograft mouse models. PROTAC MLKL Degrader-2 can be used in cancer-related research .
loading...
    loading...
Cat. No.: HY-169073
CAS No.: 2093389-19-4
TC13172-NH-COOH is a PROTAC target protein ligand (Ligands for Target Protein for PROTACs). TC13172-NH-COOH can be used for synthesis PROTAC MLKL Degrader-2 (HY-169072) .
loading...
    loading...
Cat. No.: HY-169074
CAS No.: 2924858-30-8
Research Areas:  

Cancer

Thalidomide-N-methylpiperazine is an E3 Ligase Ligand-Linker Conjugate. Thalidomide-N-methylpiperazine can be used to synthesize PROTAC MLKL Degrader-2 (HY-169072) to exhibit antinecroptotic activity on human cell lines and effectively degrade MLKL in the HT-29 xenograft mouse model .
loading...
    loading...
Cat. No.: HY-182344
MLKL ligand-2 is a mixed lineage kinase domain-like pseudokinase (MLKL) PROTAC ligand with a KD of 9.408 μM. MLKL ligand-2 forms hydrogen bond networks and hydrophobic interactions with specific MLKL residues, and stabilizes MLKL in hepatic cells. MLKL ligand-2 can be used to synthesize PROTAC MLKL Degrader-3 (HY-182343) .
loading...
    loading...